Nimbus Therapeutics
Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.
About
Technology stack
detected 2026-06-15No comments yet. Be the first to share your take.
What does Nimbus Therapeutics do?
Nimbus Therapeutics is a clinical-stage biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine. They focus on precision small molecule design for targets implicated in multiple human diseases, including oncology, immunology, and metabolic disorders. Their approach combines cutting-edge computational chemistry, structural biology, and machine learning to accelerate the drug discovery and development process.
How much funding has Nimbus Therapeutics raised?
Nimbus Therapeutics has raised a total of $589M in funding. The most recent round on record is Series F.
Where is Nimbus Therapeutics headquartered?
Nimbus Therapeutics is headquartered in Boston, United States.
When was Nimbus Therapeutics founded?
Nimbus Therapeutics was founded in 2009.
What industry does Nimbus Therapeutics operate in?
Nimbus Therapeutics operates in Biotechnology, Drug Discovery, AI, Machine Learning, Small Molecule Therapeutics.